Alex Zhavoronkov, Insilico CEO

No hu­mans al­lowed: Alex Zha­voronkov adds ro­bot­ic lab to his AI drug dis­cov­ery play as In­sil­i­co un­veils $60M raise

For Alex Zha­voronkov, the re­cent biotech mar­ket down­turn is, in fact, a good thing.

The In­sil­i­co CEO — in his sig­na­ture con­fi­dent ex­u­ber­ance — said the cri­sis …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.